Views & Analysis | Perspectives on pharma industry issues

Oncology

On GDF-15 neutralisation and cachexia, with CatalYm

As ESMO 2026 continues to get underway, pharmaphorum web editor Nicole Raleigh spoke with Scott Clarke, CEO of CatalYm.

Oncology

pharmaphorum podcast Episode 282 at ESMO26: Dr Chuck Link, Syncromune

ESMO26: Lowering toxicity, extending lives, with Syncromune

As the ESMO26 Congress commences in Madrid, pharmaphorum invited Syncromune Executive Chairman Dr Chuck Link onto the podcast.

Oncology

Why precision biomarkers will change the future of breast ca...

Blood-based biomarkers can provide an earlier, dynamic view of what is happening inside a patient, creating an opportunity to detect changes sooner.

Sales & Marketing

Benefits of marketing with AI tools, upward trajectory graph

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Oncology

Sponsored

12 Questions with Julia Jakl

Learn more about Julia Jakl, VP and Business Unit Head, Oncology UK at GSK, in a new 12 Questions With.

Articles

Editor’s voice: November – marketing excellence, Barack Obam...

pharmaphorum’s Managing Editor, Rebecca Aris, shares her content highlights from November, which was themed on the topic of marketing excellence, and reveals what to look forward to in December. Our content focus this month was on the theme of ‘Marketing excellence’. We published no less than 26 content pieces in...

Articles

Physician perspectives: Bertalan Mesko, MD, PhD

We follow up with social media expert, Bertalan Mesko, to find out what he got up to in 2012 and his thoughts on the continually evolving field of social media in healthcare. Social media is continually evolving. Almost every day now sees the launch of either a new social media channel or a...

Articles

Pharma HCP meetings – here today gone tomorrow?

As our med comms focus month continues, Mark Handforth shares his views on the future of pharma HCP meetings. This isn’t an article bemoaning that “meetings aren’t what they used to be” - well OK, maybe in part - but what I do...

Sales & Marketing

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Sales & Marketing

Building a social presence inside regulatory guardrails

In the UK, promoting prescription-only medicines to the public is prohibited by law and by the ABPI Code - social media reactions and shares included.

Digital

Sponsored

Why AI transformation is really about people

Jeff Kaminski, global head of AI and data at Axtria and a former industry analyst, discusses culture, governance, and leadership challenges around AI.

Digital